ELENA FORSTER: Open Payments
NPI 1932346095 · MEDFORD, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$611 in 30 payments from 10 companies in 2025. Trend: 2023 $686 · 2024 $402 · 2025 $611
Food & beverage: $611
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $162 |
| GENZYME CORPORATION | 4 | $90 |
| Galderma Laboratories, L.P. | 4 | $80 |
| UCB, Inc. | 4 | $80 |
| Janssen Biotech, Inc. | 3 | $48 |
| Lilly USA, LLC | 2 | $38 |
| Regeneron Healthcare Solutions, Inc. | 1 | $32 |
| Biocon Biologics Inc | 1 | $32 |
| Novartis Pharmaceuticals Corporation | 1 | $31 |
| LEO Pharma Inc. | 1 | $18 |
Products named: SKYRIZI, DUPIXENT, Bimzelx, TREMFYA, NEMLUVIO, TALTZ, AKLIEF, RINVOQ.
Industry payments across OR — which companies pay providers there.
